Article
Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.
Haematologica - 1 Oct 2005
Sarasquete María Eugenia, García-Sanz Ramón, González David, Martínez Joaquín, Mateo Gema, Martínez Pilar, Ribera José Maria, Hernández José Mariano, Lahuerta Juan José, Orfão Alberto, González Marcos, San Miguel Jesus F
Abstract excerpt
BACKGROUND AND OBJECTIVES: Minimal residual disease (MRD) studies are useful in multiple myeloma (MM). However, the definition of the best technique and clinical utility are still unresolved issues. The aim of this study was to analyze and compare the clinical utility of MRD studies in MM with tw...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.